You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 9,474,746

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,474,746 protect, and when does it expire?

Patent 9,474,746 protects ACUVUE THERAVISION WITH KETOTIFEN and is included in one NDA.

This patent has twenty-one patent family members in twelve countries.

Summary for Patent: 9,474,746

Title:	Methods for stabilizing oxidatively unstable compositions
Abstract:	Ophthalmic compositions and methods of preparing such compositions are disclosed.
Inventor(s):	Mahadevan; Shivkumar (Orange Park, FL), Molock; Frank (Orange Park, FL), Khanolkar; Vandeeta (Jacksonville, FL)
Assignee:	Johnson & Johnson Vision Care, Inc. (Jacksonville, FL)
Application Number:	13/894,482
Patent Claim Types: see list of patent claims	Composition; Delivery;

Drugs Protected by US Patent 9,474,746

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Johnson Johnson Visn	ACUVUE THERAVISION WITH KETOTIFEN	ketotifen fumarate	DRUG-ELUTING CONTACT LENS;OPHTHALMIC	022388-001	Feb 25, 2022		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,474,746

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	059927	⤷ Sign Up
Australia	2007227091	⤷ Sign Up
Brazil	PI0709549	⤷ Sign Up
Canada	2646424	⤷ Sign Up
Canada	2908828	⤷ Sign Up
China	101420934	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.